ethosuximide has been researched along with Substance Withdrawal Syndrome in 7 studies
Ethosuximide: An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
ethosuximide : A dicarboximide that is pyrrolidine-2,5-dione in which the hydrogens at position 3 are substituted by one methyl and one ethyl group. An antiepileptic, it is used in the treatment of absence seizures and may be used for myoclonic seizures, but is ineffective against tonic-clonic seizures.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Here, we expand on these findings to test whether ethosuximide can reduce the sensitivity to pentylenetetrazole-induced seizures during ethanol withdrawal." | 3.81 | Ethosuximide Reduces Mortality and Seizure Severity in Response to Pentylenetetrazole Treatment During Ethanol Withdrawal. ( Godwin, DW; Masicampo, ML; Riegle, MA; Shan, HQ; Xu, V, 2015) |
| " Dose-response curves for the convulsive effect of pentylenetetrazol obtained at the peak of the withdrawal signs shifted greatly to the left in alcohol withdrawn animals but less in barbital withdrawn animals." | 1.27 | Differentiation of alcohol and barbital physical dependence. ( Kaneda, H; Kaneto, H; Kawatani, S, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riegle, MA | 1 |
| Masicampo, ML | 1 |
| Shan, HQ | 1 |
| Xu, V | 1 |
| Godwin, DW | 2 |
| Wiggins, WF | 1 |
| Graef, JD | 1 |
| Huitt, TW | 1 |
| Aminoff, MJ | 1 |
| Kaneto, H | 1 |
| Kawatani, S | 1 |
| Kaneda, H | 1 |
| Norton, PR | 1 |
| Hill, RM | 1 |
| Verniaud, WM | 1 |
| Horning, MG | 1 |
| McCulley, LB | 1 |
| Morgan, NF | 1 |
7 other studies available for ethosuximide and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Ethosuximide Reduces Mortality and Seizure Severity in Response to Pentylenetetrazole Treatment During Ethanol Withdrawal.
Topics: Alcoholism; Animals; Anticonvulsants; Ethosuximide; Male; Mice; Mice, Inbred DBA; Mortality; Pentyle | 2015 |
Ethosuximide reduces ethanol withdrawal-mediated disruptions in sleep-related EEG patterns.
Topics: Animals; Brain; Electroencephalography; Ethanol; Ethosuximide; Male; Mice; Mice, Inbred C57BL; Sleep | 2013 |
Drug treatment of epilepsy.
Topics: Anticonvulsants; Carbamazepine; Clonazepam; Electroencephalography; Epilepsy; Ethosuximide; Female; | 1981 |
Differentiation of alcohol and barbital physical dependence.
Topics: Animals; Barbital; Barbiturates; Diazepam; Ethanol; Ethosuximide; Male; Mice; Morphine; Naloxone; Pe | 1986 |
The effects of drugs on barbiturate withdrawal convulsions in the rat.
Topics: Animals; Barbiturates; Chlordiazepoxide; Chlorpromazine; Ethanol; Ethosuximide; Female; Humans; Hydr | 1970 |
Anticonvulsant drugs in idiopathic epilepsy.
Topics: Acetazolamide; Anticonvulsants; Epilepsy; Epilepsy, Absence; Ethosuximide; Humans; Hydantoins; Mepho | 1970 |
Infants exposed in utero to antiepileptic drugs. A prospective study.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Amitriptyline; Amniotic Fluid; Anticonvulsants; Chro | 1974 |